1. Abernethy H, Cho C, DeLanoy A, et al. Clinical inquiries.
What nonpharmacological treatments are effective against common nongenital warts? J Fam Pract.
2006;55(9):801-802.
2. Al Yahya RS. Treatment of primary cutaneous amyloidosis with laser: A review of the literature.
Lasers Med Sci. 2016;31(5):1027-1035.
3. Aldahan AS, Shah VV, Mlacker S, et al. Laser and light treatments for striae distensae: A comprehensive review of the literature. Am J Clin Dermatol. 2016;17 (3):239-256.
4. Al-Himdani S, Ud-Din S, Gilmore S, Bayat A. Striae distensae: A comprehensive review and evidence-
based evaluation of prophylaxis and treatment. Br J Dermatol. 2014;170(3):527-547.
5. Alster TS. Laser treatment of hypertrophic scars, keloids, and striae. Dermatol Clin. 1997;15(3):419-429.
6. Barbaric J, Abbott R, Posadzki P, et al. Light therapies for acne: Abridged Cochrane systematic review
including GRADE assessments. Br J Dermatol. 2018;178 (1):61-75.
7. Barnes L, Estes SA Laser treatment of hereditary multiple glomus tumors. J Dermatol Surg Oncol.
1986;12(9):912-915.
8. Berman B, Flores F. The treatment of hypertrophic scars and keloids. Eur J Dermatol. 1998;8(8):591-595.
9. Bernstein EF, Bhawalkar J, Clifford J, et al. Laser treatment of dyschromia with a novel 607 nm pulsed- dye laser. J Drugs Dermatol. 2011;10(4):388-394.
10. Bouzari N, Davis SC, Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol. 2007;46 (1):80-88.
11. Burgdorf WHC. Benign lymphangioendothelioma.
eMedicine Dermatology. New York, NY: Medscape;
updated March 10, 2009. Available at:
http://emedicine.medscape.com/article/1086719-overview. Accessed June 11, 2010.
12. Chang CW, Ries WR. Nonoperative techniques for scar management and revision. Facial Plast Surg. 2001;17 (4):283-288.
13. Charakida A, Seaton ED, Charakida M, et al.
Phototherapy in the treatment of acne vulgaris: What is its role? Am J Clin Dermatol. 2004;5(4):211-216.
14. Chartier TK, Aasi SZ. Treatment and prognosis of basal cell carcinoma. UpToDate [online serial]. Waltham, MA:
UpToDate; reviewed April, 2014.
15. Chatrath V, Rohrer TE. Granuloma faciale successfully treated with long-pulsed tunable dye laser. Dermatol Surg. 2002;28(6):527-529.
16. Cooper SM, Burge SM. Darier's disease: Epidemiology, pathophysiology, and management. Am J Clin
Dermatol. 2003;4(2):97-105.
17. De Leeuw J, Van Lingen RG, Both H, et al. A
comparative study on the efficacy of treatment with 585 nm pulsed dye laser and ultraviolet B-TL01 in plaque type psoriasis. Dermatol Surg. 2009;35(1):80-91.
18. de Vries FMC, Meulendijks AM, Driessen RJB, et al. The efficacy and safety of non-pharmacological therapies for the treatment of acne vulgaris: A systematic review and best-evidence synthesis. J Eur Acad Dermatol Venereol. 2018;32(7):1195-1203.
19. Eisen D, Alster TS. Use of a 585 nm pulsed dye laser for the treatment of morphea. Dermatol Surg. 2002; 28 (7):615-616.
20. El-Naby NA, Hawwam SA, Ali MM, Sarhan N. The clinical and electron microscopic evaluation of the impact of pulsed dye laser techniques on solar lentigines (randomized clinical trial). J Dermatolog Treat. 2020 Apr 11 [Online ahead of print].
21. Elsaie ML, Ibrahim SM. The effect of pulsed dye laser on cutaneous leishmaniasis and its impact on the Dermatology Life Quality Index. J Cosmet Laser Ther.
2018;20(3):152-155.
22. Elston DM. Treatment of granuloma faciale with the pulsed dye laser. Cutis. 2000;65(2):97-98.
23. English RS, Shenefelt PD. Keloids and hypertrophic scars. Dermatol Surg. 1999;25(8):631-638.
24. Falto-Aizpurua LA, Griffith RD, Yazdani Abyaneh MA, Nouri K. Laser therapy for the treatment of Hailey-Hailey disease: A systematic review with focus on carbon dioxide laser resurfacing. J Eur Acad Dermatol Venereol. 2015 ;29(6):1045-1052.
25. Fisher GH, Geronemus RG. Improvement of familial benign pemphigus after treatment with pulsed-dye
laser: A case report. Dermatol Surg. 2006;32(7):966-968.
26. Foerster V, Murtagh J, Fiander M. Pulsed dye laser therapy of port wine stains. Technology Report No. 78.
Ottawa, ON: Canadian Agency for Drugs and Technologies in Health (CADTH); 2007.
27. Forbat E, Al-Niaimi F. Nonvascular uses of pulsed dye laser in clinical dermatology. J Cosmet Dermatol.
2019;18(5):1186-1201.
28. Gibbs S, Harvey I. Topical treatments for cutaneous warts. Cochrane Database Syst Rev. 2006;
(3):CD001781.
29. Goldberg DJ. Lasers and light sources for rosacea.
Cutis. 2005;75(3 Suppl):22-26; discussion 33-36.
30. Goldstein BG, Goldstein AO. Oral lesions. UpToDate [online serial]. Waltham, MA: UpToDate; reviewed April 2015.
31. Gonzalez S, Vibhagool C, Falo LD Jr, et al. Treatment of pyogenic granulomas with the 585 nm pulsed dye laser. J Am Acad Dermatol. 1996;35(3 Pt 1):428-431.
32. Gungor S, Sayilgan T, Gokdemir G, Ozcan D. Evaluation of an ablative and non-ablative laser procedure in the treatment of striae distensae. Indian J Dermatol Venereol Leprol. 2014;80(5):409-412.
33. Haedersdal M, Togsverd-Bo K, Wulf HC. Evidence-based review of lasers, light sources and photodynamic therapy in the treatment of acne vulgaris. J Eur Acad Dermatol Venereol. 2008;22(3):267-278.
34. Hamilton MM. Laser treatment of pigmented and vascular lesions in the office. Facial Plast Surg. 2004;20 (1):63-69.
35. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Laser Ther. 2011;13(1):2-5.
36. Hohenleutner S, Badur-Ganter E, Landthaler M, et al.
Long-term results in the treatment of childhood
hemangioma with the flashlamp-pumped pulsed dye laser: An evaluation of 617 cases. Lasers Surg Med.
2001;28(3):273-277.
37. Hrebinko RL. Circumferential laser vaporization for severe meatal stenosis secondary to balanitis xerotica obliterans. J Urol. 1996;156(5):1735-1736.
38. Jacobsen E, McGraw R, McCagh S. Pulsed dye laser efficacy as initial therapy for warts and against recalcitrant verrucae. Cutis. 1997;59(4):206-208.
39. Jalian HR, Avram MM, Stankiewicz KJ, et al. Combined 585 nm pulsed-dye and 1,064 nm Nd:YAG lasers for the treatment of basal cell carcinoma. Lasers Surg Med. 2014;46(1):1-7.
40. Jeong GJ, Kwon HJ, Park KY, Kim BJ. Pulsed-dye laser as a novel therapeutic approach for post-filler bruises.
Dermatol Ther. 2018;31(6):e12721.
41. Karsai S, Czarnecka A, Raulin C. Treatment of
xanthelasma palpebrarum using a pulsed dye laser: A prospective clinical trial in 38 cases. Dermatol Surg.
2010;36(5):610-617.
42. Karsai S, Schmitt L, Raulin C. The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: A randomized controlled single-blinded trial. Br J Dermatol. 2010;163(2):395-401.
43. Katugampola GA, Lanigan SW. Five years' experience of treating port wine stains with the flashlamp-pumped pulsed dye laser. Br J Dermatol. 1997;137 (5):750-754.
44. Keefer CJ, Brantley B, DeLozier JB 3rd. Familial infiltrative glomangiomas: Diagnosis and treatment. J Craniofac Surg. 1996;7(2):145-147.
45. Kenton-Smith J, Tan ST. Pulsed dye laser therapy for viral warts. Br J Plast Surg. 1999;52(7):554-558.
46. Khaled A, Jones M, Zermani R, et al. Granuloma faciale.
Pathologica. 2007;99(5):306-308.
47. Khan R. Lasers in plastic surgery. J Tissue Viability.
2001;11(3):103-107, 110-112.
48. Komericki P, Akkilic M, Kopera D. Pulsed dye laser treatment of genital warts. Lasers Surg Med. 2006;38 (4):273-276.
49. Kotsakis GA, Konstantinidis I, Karoussis IK, et al.
Systematic review and meta-analysis of the effect of various laser wavelengths in the treatment of peri-implantitis. J Periodontol. 2014;85(9):1203-1213.
50. Kravvas G, Veitch D, Al-Niaimi F. The use of energy devices in the treatment of striae: A systematic literature review. J Dermatolog Treat. 2019;30(3):294-302.
51. Leonardi-Bee J, Batta K, O'Brien C, Bath-Hextall FJ.
Interventions for infantile haemangiomas (strawberry birthmarks) of the skin, Cochrane Database Syst Rev.
2011;(5):CD006545.
52. Lima AL, Goetze S, Illing T, Elsner P. Light and laser modalities in the treatment of cutaneous sarcoidosis:
A systematic review. Acta Derm Venereol. 2018;98 (5):481-483.
53. Liu A, Moy RL, Ross EV, et al. Pulsed dye laser and pulsed dye laser-mediated photodynamic therapy in the treatment of dermatologic disorders. Dermatol Surg. 2012;38(3):351-366.
54. Lupton JR, Alster TS. Laser scar revision. Dermatol Clin.
2002;20(1):55-65.
55. Ma D, Li Q, Jin D, et al. A case of lupus miliaris
disseminatus faciei that was successfully treated with 595 nm pulsed-dye laser combined with drugs.
Dermatol Ther. 2020 Apr 3 [Online ahead of print].
56. MacGregor JL, Wesley NO. Striae distensae (stretch marks). UpToDate [online serial]. Waltham, MA:
UpToDate; reviewed March 2017.
57. Maranda EL, Nguyen AH, Lim VM, et al. Laser and light therapies for the treatment of nail psoriasis. J Eur Acad Dermatol Venereol. 2016;30(8):1278-1284.
58. Maw R. Critical appraisal of commonly used treatment for genital warts. Int J STD AIDS. 2004;15(6):357-364.
59. McClean K, Hanke CW. The medical necessity for treatment of port-wine stains. Dermatol Surg. 1997;23 (8):663-667.
60. Minars N, Blyumin-Karasik M. Treatment of basal cell carcinomas with pulsed dye laser: A case series. J Skin Cancer. 2012;2012:286480.
61. Mortensen MM, Woo P, Ivey C, et al. The use of the pulse dye laser in the treatment of vocal fold scar: A preliminary study. Laryngoscope. 2008;118(10):1884-1888.
62. Munavalli GS, Weiss RA. Evidence for laser- and light-based treatment of acne vulgaris. Semin Cutan Med Surg. 2008;27(3):207-211.
63. National Comprehensive Cancer Network (NCCN).
Basal cell and squamous cell skin cancers. NCCN Clinical Practice Guidelines in Oncology, Version 2.2014. Fort Washington, PA: NCCN; 2014.
64. Natto ZS, Aladmawy M, Levi PA Jr, Wang HL.
Comparison of the efficacy of different types of lasers for the treatment of peri-implantitis: A systematic review. Int J Oral Maxillofac Implants. 2015;30(2):338-345.
65. Nguyen J, Chapman LW, Korta DZ, Zachary CB. Laser treatment of cutaneous angiokeratomas: A systematic review. Dermatol Ther. 2017;30(6).
66. Ockenfels HM, Hammes S. [Laser treatment of warts].
Hautarzt. 2008;59(2):116-123.
67. O'Mahony C. Genital warts: Current and future management options. Am J Clin Dermatol. 2005;6 (4):239-243.
68. Orringer JS, Kang S, Hamilton T. Treatment of acne vulgaris with a pulsed dye laser: A randomized controlled trial. JAMA. 2004;291(23):2834-2839.
69. Orringer JS, Sachs DL, Bailey E, et al. Photodynamic therapy for acne vulgaris: A randomized, controlled, split-face clinical trial of topical aminolevulinic acid and
pulsed dye laser therapy. J Cosmet Dermatol. 2010;9 (1):28-34.
70. Park YM, Jo KH, Hong HJ, Choi HS. Phonatory outcome of 585 nm/pulsed-dye laser in the management of glottic leukoplakia. Auris Nasus Larynx. 2014;41(5):459-463.
71. Pokala N, Kiran RP. Hidradenitis suppurativa.
eMedicine General Surgery Topic 2717. Omaha, NE:
eMedicine.com; updated August 19, 2002. Available at:
http://www.emedicine.com/med/topic2717.htm.
Accessed July 8, 2003.
72. Rebora A. The management of rosacea. Am J Clin Dermatol. 2002;3(7):489-496.
73. Robson KJ, Cunningham NM, Kruzan KL, et al. Pulsed-dye laser versus conventional therapy in the treatment of warts: A prospective randomized trial. J Am Acad Dermatol. 2000;43(2 Pt 1):275-280.
74. Ross BS, Levine VJ, Nehal K, et al. Pulsed dye laser treatment of warts: An update. Dermatol Surg.
1999;25(5):377-380.
75. Ross NA, Ho D, Fisher J, et al. Striae distensae:
Preventative and therapeutic modalities to improve aesthetic appearance. Dermatol Surg. 2017;43(5):635-648.
76. Scheinfeld N, Lehman DS. An evidence-based review of medical and surgical treatments of genital warts.
Dermatol Online J. 2006;12(3):5.
77. Schmitt L, Roos S, Raulin C, Karsai S. Segmental Darier disease: Treatment with pulsed dye laser. Hautarzt.
2009;60(12):995-998.
78. Seaton ED, Charakida A, Mouser PE, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris:
Randomised controlled trial. Lancet. 2003;362 (9393):1347-1352.
79. Shah M, Kingston TP, Cotterill JA. Eruptive pyogenic granulomas: A successfully treated patient and review of the literature. Br J Dermatol. 1995;133(5):795-796.
80. Sharma JK, Miller R. Treatment of multiple
glomangioma with tuneable dye laser. J Cutan Med Surg. 1999;3(3):16716-8.
81. Shen L, Zhou G, Zhao J, et al. Pulsed dye laser therapy for infantile hemangiomas: A systemic review and meta-analysis. QJM. 2015;108(6):473-480.
82. Slaoui W, Chiheb S, Benchikhi H. Efficacy of pulsed-dye laser on residual red lesions of cutaneous
leishmaniasis. Ann Dermatol Venereol. 2015;142(1):17-20.
83. Tay YK, Weston WL, Morelli JG. Treatment of pyogenic granuloma in children with the flashlamp-pumped pulsed dye laser. Pediatrics. 1997;99(3):368-370.
84. Tirico MCCP, Jensen D, Green C, Ross EV. Short pulse intense pulsed light versus pulsed dye laser for the treatment of facial redness. J Cosmet Laser Ther.
2020;22(2):60-64.
85. van Zuuren EJ, Fedorowicz Z, Carter B, et al.
Interventions for rosacea. Cochrane Database Syst Rev. 2015;4:CD003262.
86. van Zuuren EJ, Graber MA, Hollis S, et al. Interventions for rosacea. Cochrane Database Syst Rev. 2005;
(3):CD003262.
87. Verne SH, Kennedy J, Falto-Aizpurua LA, et al. Laser treatment of granuloma annulare: A review. Int J Dermatol. 2016;55(4):376-381.
88. Webster GF. Laser treatment of acne. Lancet. 2003;362 (9393):1342.
89. Wiederkehr M, Schwartz RA. Granuloma faciale.
eMedicine Dermatology. New York, NY: Medscape;
May 23, 2008. Available at:
http://emedicine.medscape.com/article/1083474-treatment. Accessed June 22, 2009.
90. Wirth FA, Lowitt MH. Diagnosis and treatment of cutaneous vascular lesions. Am Fam Physician.
1998;57(4):765-773.
Copyright Aetna Inc. All rights reserved. Clinical Policy Bulletins are developed by Aetna to assist in administering plan benefits and constitute neither offers of coverage nor medical advice. This Clinical Policy Bulletin contains only a partial, general description of plan or program benefits and does not constitute a contract. Aetna does not provide health care services and, therefore, cannot guarantee any results or outcomes. Participating providers are independent contractors in private practice and are neither employees nor agents of Aetna or its affiliates. Treating providers are solely responsible for medical advice and treatment of members. This Clinical Policy Bulletin may be updated and therefore is subject to change.
Copyright © 2001-2020 Aetna Inc.